Augmentation of high molecular weight kininogen and reduction of kallikrein activity in plasma of L-NAME hypertensive rats.

被引：0

作者：

Sendäo, AP ^{[1
]}

Poggi, JC ^{[1
]}

Bendhack, LM ^{[1
]}

Reis, ML ^{[1
]}

机构：

[1] Univ Sao Paulo, Coll Pharmaceut Sci Ribeirao Preto, Pharmacol Lab, BR-14040903 Ribeirao Preto, SP, Brazil

来源：

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

P1515

引用

页码：R337 / R337

页数：1

共 50 条

[21] HIGH MOLECULAR-WEIGHT KININOGEN - ITS INABILITY TO CORRECT THE CLOTTING OF KININOGEN-DEFICIENT PLASMA AFTER CLEAVAGE OF BRADYKININ BY PLASMA KALLIKREIN, PLASMIN OR TRYPSIN
CHAN, JYC
MOVAT, HZ
BURROWES, CE
THROMBOSIS RESEARCH, 1979, 14 (06) : 817 - 824
[22] REDUCED COFACTOR FUNCTION OF HUMAN HIGH MOLECULAR-WEIGHT KININOGEN INDUCED BY HUMAN-PLASMA KALLIKREIN
THIDEMANN, H
BRISEID, K
ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1984, 55 (01): : 25 - 32
[23] Bradykinin release from high molecular weight kininogen and increase in plasma kallikrein-like activity following sensory stimulation by food in the rat
A. M. Rothschild
Eleni L. T. Gomes
Ivanilda C. Fortunato
Naunyn-Schmiedeberg's Archives of Pharmacology, 1998, 358 : 483 - 488
[24] Bradykinin release from high molecular weight kininogen and increase in plasma kallikrein-like activity following sensory stimulation by food in the rat
Rothschild, AM
Gomes, ELT
Fortunato, IC
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (04) : 483 - 488
[25] HUMAN HIGH MOLECULAR-WEIGHT KININOGEN - EFFECTS OF CLEAVAGE BY KALLIKREIN ON PROTEIN-STRUCTURE AND PROCOAGULANT ACTIVITY
SCHIFFMAN, S
MANNHALTER, C
TYNER, KD
JOURNAL OF BIOLOGICAL CHEMISTRY, 1980, 255 (13) : 6433 - 6438
[26] SURFACE-INDUCED ALTERATIONS IN THE KINETIC PATHWAY FOR CLEAVAGE OF HUMAN HIGH-MOLECULAR-WEIGHT KININOGEN BY PLASMA KALLIKREIN
TAYEH, MA
OLSON, ST
SHORE, JD
JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (23) : 16318 - 16325
[27] HIGH MOLECULAR-WEIGHT KININOGEN PROTECTS HUMAN-PLASMA KALLIKREIN AGAINST INACTIVATION BY CL-INHIBITOR
SCHAPIRA, M
SCOTT, C
BACON, R
COLMAN, RW
CLINICAL RESEARCH, 1980, 28 (02): : A497 - A497
[28] ISOLATION OF A CATIONIC FRAGMENT OF HIGH MOLECULAR MASS KININOGEN AND EFFECT OF THIS FRAGMENT ON HUMAN-PLASMA KALLIKREIN ACTIVITY
YAROVAYA, GA
DOTSENKO, VL
OREKHOVICH, VN
CLINICA CHIMICA ACTA, 1982, 123 (03) : 261 - 267
[29] CHANGES IN PLASMA-LEVELS OF PREKALLIKREIN, KALLIKREIN, HIGH MOLECULAR-WEIGHT KININOGEN AND KALLIKREIN INHIBITORS DURING LETHAL ENDOTOXIN-SHOCK IN DOGS
GALLIMORE, MJ
AASEN, AO
AMUNDSEN, E
HAEMOSTASIS, 1978, 7 (2-3) : 79 - 84
[30] AT1 receptor antisense gene therapy prevents the development of high blood pressure in L-NAME treated rats.
Reaves, PY
Francis, SC
Beck, CR
Katovich, MJ
Raizada, MK
HYPERTENSION, 2001, 38 (03) : 495 - 495

← 1 2 3 4 5 →